Research, Action & Innovative Solutions for IBD
Today’s Insights IBD is dedicated to advancing scientific breakthroughs and implementing innovative care solutions. By connecting communities and stakeholders, I aim to amplify the impact of shared knowledge and strenghten collaboration.
With the alarming rise in IBD cases worldwide, it’s crucial to move beyond discussions and take decisive action on a global scale. As a patient advocate, I am deeply concerned about the suffering of patients. Living with IBD is incredibly challenging, as it brings both physical and mental burdens. Therefore, I am focusing on two key questions: What steps can we take right now to improve patient care globally? And how can we leverage existing data to optimize research and drive better patient outcomes?
I aim to share valuable knowledge inspired by the IBD community, while exploring opportunities for collaboration with healthcare professionals and researchers.
Founder
I’m Raihaneh, living in the Netherlands, and the founder of Today’s Insights IBD. I hold a Master’s degree in Management, specializing in Strategy & Innovation, and a Bachelor’s degree in Social Work & Services. My professional background is diverse, encompassing experience in both the for-profit and nonprofit sectors, including strategic planning, business consultancy, marketing, digital strategies and board participation.
In 2020, I was diagnosed with inflammatory bowel disease, a life-altering event that opened my eyes to the many challenges patients face. This inspired me to become an active patient advocate. In my role as a patient representative, I have contributed to advancing IBD research, helping to bridge the gap between patients and the scientific community. I am also a Board member of Propel a Cure for Crohn’s Disease, a nonprofit organization committed to funding groundbreaking early-stage research.
My advocacy focuses on driving faster, results-driven progress in IBD healthcare, with primary interests in:
• New medical discoveries and treatments by strengthening knowledge exchange across networks
• Awareness of bile acids and bile acid malabsorption as important therapeutic targets across gastrointestinal conditions
• Optimizing current IBD treatment by supporting the role of evidence-based nutrition alongside medical care
If you are interested in collaborating with me, or my consultancy services, please send an email to info@todaysinsightsibd.com.